IDENTIFICATION OF NOVEL ANTIGENS FOR VACCINATION AND IMMUNOTHERAPY AGAINST THE HUMAN GASTRIC PATHOGEN, HELICOBACTER PYLORI -

Grant number: LP0560720

Abstract

The bacterium Helicobacter pylori is a significant human pathogen which infects the stomach where it is the major cause of stomach and duodenal ulcers, plus two types of cancer. This project proposes to utilise a novel strategy to identify potential vaccine targets on the bacterial surface with the aim to develop an effective vaccine against this organism. Such a vaccine would protect against the development of stomach cancer, hence saving lives, plus significantly reduce the incidence of stomach ulcers, thereby reducing suffering of individuals and providing financial benefits to employers.

Researchers